Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03880812 · ClinicalTrials.gov registry record · NA

Cost Information on Carpal Tunnel Syndrome Treatment Decisions

A NA study of Carpal Tunnel Syndrome, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
184
Enrollment target
6
Study locations

NCT03880812 is a NA study of Carpal Tunnel Syndrome that has completed, run by University of Texas at Austin. The registered enrollment target is 184 participants, below the 214-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (14% lower). The trial reports 6 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03880812, a NA study of Carpal Tunnel Syndrome, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
184 participants
Enrollment target
6
Study locations

Study Summary

The purpose of this study was to determine whether the provision of societal cost information affects patients' decisions whether or not to undergo surgical management in carpal tunnel syndrome, using a hypothetical scenario.

Conditions Studied

Interventions

  • OTHER Societal cost

Study Locations (6)

Texas

  • Austin Regional Clinic - Austin
  • Texas Orthopedics - Austin
  • HTB Musculoskeletal Institute - Austin
  • Seton Institute for Plastic and Reconstructive Surgery - Austin
  • Orthopedic Specialists of Austin - Austin
  • ATX Ortho - Austin

Trial Details

FieldValue
Enrollment Target 184 participants
Start Date 2018-09-24
Est. Completion 2018-12-26
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT03880812

The ClinicalTrials.gov registry entry for NCT03880812 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 214-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (14% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Carpal Tunnel Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Societal cost is the first listed.

NCT03880812 reports 6 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03880812 about?

NCT03880812 is a clinical study titled "Cost Information on Carpal Tunnel Syndrome Treatment Decisions". The purpose of this study was to determine whether the provision of societal cost information affects patients' decisions whether or not to undergo surgical management in carpal tunnel syndrome, using a hypothetical scenario.

What is the current status of trial NCT03880812?

This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2018-09-24. Estimated completion is 2018-12-26.

What conditions does trial NCT03880812 study?

This clinical trial studies the following conditions: Carpal Tunnel Syndrome.

What interventions are being tested in trial NCT03880812?

The interventions under investigation include: Societal cost (OTHER).

Who is sponsoring clinical trial NCT03880812?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03880812 being conducted?

This trial has 6 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Carpal Tunnel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.